1. Academic Validation
  2. Amelioration of Cisplatin-induced Renal Inflammation by Recombinant Human Golimumab in Mice

Amelioration of Cisplatin-induced Renal Inflammation by Recombinant Human Golimumab in Mice

  • Curr Pharm Biotechnol. 2022;23(7):970-977. doi: 10.2174/1389201022666210810141139.
Vishal Pavitrakar 1 2 Rustom Mody 3 Selvan Ravindran 2
Affiliations

Affiliations

  • 1 Division of Biotechnology, Lupin Limited, Pune, India.
  • 2 Faculty of Health Sciences, Symbiosis School of Biological Sciences, Selvan Ravindran, Symbiosis International (Deemed) University, Pune, India.
  • 3 Division of Biotechnology, Lupin Limited, Pune, India (Currently associated with Sun Pharma Advanced Research Company Ltd., Vadodara, Gujarat, India).
Abstract

Background: One of the most commonly used anti-cancer agents, Cisplatin (CDDP) often causes nephrotoxicity by eliciting inflammation and oxidative stress. Golimumab, an anti-TNF biologic, is prescribed for the management of numerous inflammatory ailments like psoriatic and rheumatoid arthritis, ulcerative colitis and ankylosing spondylitis.

Objective: Current study has explored the effects of anti-TNF biologics golimumab on mice due to cisplatin-induced nephrotoxicity.

Method: Renal toxicity was caused by administration of single cisplatin injection at 22 mg/kg by intraperitoneal (i/p) route. Golimumab (24 mg/kg, s.c.) was administered consecutively for 7 days. The parameters such as renal functions, oxidative stress, inflammation, and renal damage were evaluated on the 7th day of experiments.

Results: Cisplatin administration caused nephrotoxicity as shown by a significant elevation of various parameters viz; serum creatinine, neutrophil gelatinase-associated lipocalin (NGAL), urea nitrogen (BUN), and Cystatin C. There was a significant rise in urinary clusterin, kidney injury molecule 1 (KIM-1), and β-N-acetylglucosaminidase (NAG) concentrations in the Animals treated with cisplatin. The markers of oxidative stress (malondialdehyde, reduced glutathione, and catalase), inflammation (IL-6, TNF-α, IL-10, IL-1β, MCP-1, ICAM-1, and TGF-β1), and Apoptosis (Caspase-3) were also altered in serum and/or kidneys of cisplatin Animals. Further, cisplatin-caused histopathological changes in proximal tubular cells as observed in the H&E staining of renal tissue. Golimumab treatment reduced all markers of kidney injury and attenuated cell death. Golimumab significantly reduced inflammatory cytokines TNFα, IL- 6, MCP-1, IL- 1β, ICAM-1, and TGF-β1 and increased anti-inflammatory cytokine IL-10 in cisplatin-intoxicated mice.

Conclusion: The study's results suggest that golimumab prevented nephrotoxicity induced by cisplatin- through inhibition of oxidative stress, apoptotic cell death inflammatory response, thus improving renal function.

Keywords

Cis-platin; Golimumab; anti-TNF biologics; anti-cancer agents; human recombinant golimumab; renal inflammation.

Figures
Products